Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts

Insulin resistance leads to the onset of medical conditions such as type 2 diabetes, and its development is associated with the alteration in the gut microbiota. Although it has been demonstrated that supplementation with prebiotics modulates the gut microbiota, limited evidence is available for eff...

Full description

Bibliographic Details
Main Authors: Ayako Watanabe, Takumi Tochio, Yoshihiro Kadota, Motoki Takahashi, Yasuyuki Kitaura, Hirohito Ishikawa, Takanori Yasutake, Masahiro Nakano, Hiroe Shinohara, Toru Kudo, Yuichiro Nishimoto, Yoshinori Mizuguchi, Akihito Endo, Yoshiharu Shimomura
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/9/2983
id doaj-0ed81ea2bf3f4d45847e9f1531ba5ec7
record_format Article
spelling doaj-0ed81ea2bf3f4d45847e9f1531ba5ec72021-09-26T00:51:11ZengMDPI AGNutrients2072-66432021-08-01132983298310.3390/nu13092983Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone HostsAyako Watanabe0Takumi Tochio1Yoshihiro Kadota2Motoki Takahashi3Yasuyuki Kitaura4Hirohito Ishikawa5Takanori Yasutake6Masahiro Nakano7Hiroe Shinohara8Toru Kudo9Yuichiro Nishimoto10Yoshinori Mizuguchi11Akihito Endo12Yoshiharu Shimomura13Laboratory of Nutritional Biochemistry, Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Aichi, JapanDepartment of Gastroenterology and Hepatology, Fujita Health University, Toyoake 470-1192, Aichi, JapanB Food Science Co., Ltd., Chita 478-0046, Aichi, JapanLaboratory of Nutritional Biochemistry, Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Aichi, JapanLaboratory of Nutritional Biochemistry, Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Aichi, JapanHealthcare Systems Co., Ltd., Nagoya 466-0058, Aichi, JapanHealthcare Systems Co., Ltd., Nagoya 466-0058, Aichi, JapanPreventive Medical Center, Shin Oyama City Hospital, Oyama 323-0827, Tochigi, JapanPreventive Medical Center, Shin Oyama City Hospital, Oyama 323-0827, Tochigi, JapanMetabologenomics, Inc., Tsuruoka 997-0052, Yamagata, JapanMetabologenomics, Inc., Tsuruoka 997-0052, Yamagata, JapanMetabologenomics, Inc., Tsuruoka 997-0052, Yamagata, JapanDepartment of Food, Aroma and Cosmetic Chemistry, Faculty of Bioindustry, Tokyo University of Agriculture, Abashiri 099-2493, Hokkaido, JapanDepartment of Food and Nutritional Sciences, College of Bioscience and Biotechnology, Chubu University, Kasugai 487-8501, Aichi, JapanInsulin resistance leads to the onset of medical conditions such as type 2 diabetes, and its development is associated with the alteration in the gut microbiota. Although it has been demonstrated that supplementation with prebiotics modulates the gut microbiota, limited evidence is available for effects of prebiotics on insulin resistance, especially for humans. We investigated the prebiotic effect of 1-kestose supplementation on fasting insulin concentration in obesity-prone humans and rats. In the preliminary study using rats, the hyperinsulinemia induced by high-fat diet was suppressed by intake of water with 2% (<i>w</i>/<i>v</i>) 1-kestose. In the clinical study using obese-prone volunteers, the fasting serum insulin level was significantly reduced from 6.5 µU/mL (95% CI, 5.5–7.6) to 5.3 (4.6–6.0) by the 12-week intervention with supplementation of 10 g 1-kestose/day, whereas it was not changed by the intervention with placebo (6.2 µU/mL (5.4–7.1) and 6.5 (5.5–7.6) before and after intervention, respectively). The relative abundance of fecal <i>Bifidobacterium</i> was significantly increased to 0.3244 (SD, 0.1526) in 1-kestose-supplemented participants compared to that in control participants (0.1971 (0.1158)). These results suggest that prebiotic intervention using 1–kestose may potentially ameliorate insulin resistance in overweight humans via the modulation of the gut microbiota. UMIN 000028824.https://www.mdpi.com/2072-6643/13/9/2983insulin resistanceobesityprebioticsgut microbiota<i>Bifidobacterium</i>
collection DOAJ
language English
format Article
sources DOAJ
author Ayako Watanabe
Takumi Tochio
Yoshihiro Kadota
Motoki Takahashi
Yasuyuki Kitaura
Hirohito Ishikawa
Takanori Yasutake
Masahiro Nakano
Hiroe Shinohara
Toru Kudo
Yuichiro Nishimoto
Yoshinori Mizuguchi
Akihito Endo
Yoshiharu Shimomura
spellingShingle Ayako Watanabe
Takumi Tochio
Yoshihiro Kadota
Motoki Takahashi
Yasuyuki Kitaura
Hirohito Ishikawa
Takanori Yasutake
Masahiro Nakano
Hiroe Shinohara
Toru Kudo
Yuichiro Nishimoto
Yoshinori Mizuguchi
Akihito Endo
Yoshiharu Shimomura
Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
Nutrients
insulin resistance
obesity
prebiotics
gut microbiota
<i>Bifidobacterium</i>
author_facet Ayako Watanabe
Takumi Tochio
Yoshihiro Kadota
Motoki Takahashi
Yasuyuki Kitaura
Hirohito Ishikawa
Takanori Yasutake
Masahiro Nakano
Hiroe Shinohara
Toru Kudo
Yuichiro Nishimoto
Yoshinori Mizuguchi
Akihito Endo
Yoshiharu Shimomura
author_sort Ayako Watanabe
title Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
title_short Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
title_full Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
title_fullStr Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
title_full_unstemmed Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
title_sort supplementation of 1-kestose modulates the gut microbiota composition to ameliorate glucose metabolism in obesity-prone hosts
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2021-08-01
description Insulin resistance leads to the onset of medical conditions such as type 2 diabetes, and its development is associated with the alteration in the gut microbiota. Although it has been demonstrated that supplementation with prebiotics modulates the gut microbiota, limited evidence is available for effects of prebiotics on insulin resistance, especially for humans. We investigated the prebiotic effect of 1-kestose supplementation on fasting insulin concentration in obesity-prone humans and rats. In the preliminary study using rats, the hyperinsulinemia induced by high-fat diet was suppressed by intake of water with 2% (<i>w</i>/<i>v</i>) 1-kestose. In the clinical study using obese-prone volunteers, the fasting serum insulin level was significantly reduced from 6.5 µU/mL (95% CI, 5.5–7.6) to 5.3 (4.6–6.0) by the 12-week intervention with supplementation of 10 g 1-kestose/day, whereas it was not changed by the intervention with placebo (6.2 µU/mL (5.4–7.1) and 6.5 (5.5–7.6) before and after intervention, respectively). The relative abundance of fecal <i>Bifidobacterium</i> was significantly increased to 0.3244 (SD, 0.1526) in 1-kestose-supplemented participants compared to that in control participants (0.1971 (0.1158)). These results suggest that prebiotic intervention using 1–kestose may potentially ameliorate insulin resistance in overweight humans via the modulation of the gut microbiota. UMIN 000028824.
topic insulin resistance
obesity
prebiotics
gut microbiota
<i>Bifidobacterium</i>
url https://www.mdpi.com/2072-6643/13/9/2983
work_keys_str_mv AT ayakowatanabe supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT takumitochio supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT yoshihirokadota supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT motokitakahashi supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT yasuyukikitaura supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT hirohitoishikawa supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT takanoriyasutake supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT masahironakano supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT hiroeshinohara supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT torukudo supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT yuichironishimoto supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT yoshinorimizuguchi supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT akihitoendo supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
AT yoshiharushimomura supplementationof1kestosemodulatesthegutmicrobiotacompositiontoameliorateglucosemetabolisminobesitypronehosts
_version_ 1716869679418441728